Eldorado Gold (NYSE:EGO) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.13 by 38.46 percent. This is a 50 percent decrease over earnings of $0.16 per share from the same period last year.
Biora Therapeutics’ Debt Overview
Over the past three months, shares of Biora Therapeutics Inc. (NASDAQ:BIOR) decreased by 61.54%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
